NOK 4.88
(-3.56%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 32.79 Million NOK | -7.52% |
2022 | 35.46 Million NOK | 24.32% |
2021 | 28.52 Million NOK | 8.69% |
2020 | 26.24 Million NOK | 50.28% |
2019 | 17.46 Million NOK | 9.57% |
2018 | 15.93 Million NOK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q3 | - NOK | -100.0% |
2023 Q1 | - NOK | -100.0% |
2023 Q4 | 32.79 Million NOK | 0.0% |
2023 FY | 32.79 Million NOK | -7.52% |
2023 Q2 | 35.37 Million NOK | 0.0% |
2022 FY | 35.46 Million NOK | 24.32% |
2022 Q4 | 35.46 Million NOK | 0.0% |
2022 Q2 | 32.79 Million NOK | 0.0% |
2021 Q2 | 29.92 Million NOK | 0.0% |
2021 FY | 28.52 Million NOK | 8.69% |
2021 Q4 | 28.52 Million NOK | 0.0% |
2020 FY | 26.24 Million NOK | 50.28% |
2020 Q4 | 26.24 Million NOK | 0.0% |
2019 FY | 17.46 Million NOK | 9.57% |
2018 FY | 15.93 Million NOK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aqua Bio Technology ASA | 5.69 Million NOK | -476.149% |
ArcticZymes Technologies ASA | 12.87 Million NOK | -154.749% |
BerGenBio ASA | 7.84 Million NOK | -318.181% |
Hofseth BioCare ASA | 82.54 Million NOK | 60.27% |
PCI Biotech Holding ASA | 1000.00 NOK | -3279279.0% |
Thor Medical ASA | - NOK | -Infinity% |
Ultimovacs ASA | 1.00 NOK | -3279378900.0% |